- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting caspases in cancer therapeutics
Authors
Keywords
-
Journal
BIOLOGICAL CHEMISTRY
Volume 394, Issue 7, Pages -
Publisher
Walter de Gruyter GmbH
Online
2013-04-15
DOI
10.1515/hsz-2013-0128
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Retinoids in Pediatric Onco-Hematology: the Model of Acute Promyelocytic Leukemia and Neuroblastoma
- (2012) Riccardo Masetti et al. ADVANCES IN THERAPY
- Myelodysplastic Syndromes: Therapy and Outlook
- (2012) Roger M. Lyons AMERICAN JOURNAL OF MEDICINE
- Synthesis and biological evaluation of a series of podophyllotoxins derivatives as a class of potent antitubulin agents
- (2012) Yingqian Liu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- New developments in castrate-resistant prostate cancer
- (2012) N. Shore et al. BJU INTERNATIONAL
- Urologists and oncologists: adapting to a new treatment paradigm in castration-resistant prostate cancer (CRPC)
- (2012) A. Oliver Sartor et al. BJU INTERNATIONAL
- Apoptosis-Modulating Drugs for Improved Cancer Therapy
- (2012) M. Ocker et al. EUROPEAN SURGICAL RESEARCH
- Modeling Prostate Cancer in Mice: Limitations and Opportunities
- (2012) P. J. Hensley et al. JOURNAL OF ANDROLOGY
- JR6, a new compound isolated from Justicia procumbens, induces apoptosis in human bladder cancer EJ cells through caspase-dependent pathway
- (2012) Xiao-Li He et al. JOURNAL OF ETHNOPHARMACOLOGY
- YM155 Reverses Cisplatin Resistance in Head and Neck Cancer by Decreasing Cytoplasmic Survivin Levels
- (2012) B. Kumar et al. MOLECULAR CANCER THERAPEUTICS
- A Perspective on Mammalian Caspases as Positive and Negative Regulators of Inflammation
- (2012) Seamus J. Martin et al. MOLECULAR CELL
- Phase I study of terameprocol in patients with recurrent high-grade glioma
- (2012) S. A. Grossman et al. NEURO-ONCOLOGY
- Survivin splice variants are not essential for mitotic progression or inhibition of apoptosis induced by doxorubicin and radiation
- (2012) Naduparambil Jacob et al. OncoTargets and Therapy
- Survivin in Solid Tumors: Rationale for Development of Inhibitors
- (2012) David N. Church et al. Current Oncology Reports
- YM155, a novel survivin suppressant, enhances taxane-induced apoptosis and tumor regression in a human Calu 6 lung cancer xenograft model
- (2011) Takahito Nakahara et al. ANTI-CANCER DRUGS
- Programmed Cell Death in Animal Development and Disease
- (2011) Yaron Fuchs et al. CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Significant Biological Role of Sp1 Transactivation in Multiple Myeloma
- (2011) M. Fulciniti et al. CLINICAL CANCER RESEARCH
- Antitumor Activity of YM155, a Selective Small-Molecule Survivin Suppressant, Alone and in Combination with Docetaxel in Human Malignant Melanoma Models
- (2011) Kentaro Yamanaka et al. CLINICAL CANCER RESEARCH
- The Two Faces of Interferon- in Cancer
- (2011) M. R. Zaidi et al. CLINICAL CANCER RESEARCH
- Anoikis Disruption of Focal Adhesion-Akt Signaling Impairs Renal Cell Carcinoma
- (2011) Shinichi Sakamoto et al. EUROPEAN UROLOGY
- Antisense Inhibition of Survivin Expression as a Cancer Therapeutic
- (2011) R. A. Carrasco et al. MOLECULAR CANCER THERAPEUTICS
- Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation
- (2010) Yanyuan Wu et al. BMC CANCER
- Phase I study of LY2181308, an antisense oligonucleotide against survivin, in patients with advanced solid tumors
- (2010) M. Tanioka et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The Inflammasomes
- (2010) Kate Schroder et al. CELL
- Targeting anoikis resistance in prostate cancer metastasis
- (2010) Shinichi Sakamoto et al. MOLECULAR ASPECTS OF MEDICINE
- Global Targeting of Subcellular Heat Shock Protein-90 Networks for Therapy of Glioblastoma
- (2010) M. D. Siegelin et al. MOLECULAR CANCER THERAPEUTICS
- Genomic instability — an evolving hallmark of cancer
- (2010) Simona Negrini et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Adeno-Associated Virus Harboring Fusion Gene NT4-Ant-Shepherdin Induce Cell Death in Human Lung Cancer Cells
- (2009) Tang Xiaojiang et al. CANCER INVESTIGATION
- Endogenous Tumor Suppression Mediated by PTEN Involves Survivin Gene Silencing
- (2009) M. Guha et al. CANCER RESEARCH
- Phase I Study of YM155, a Novel Survivin Suppressant, in Patients with Advanced Solid Tumors
- (2009) T. Satoh et al. CLINICAL CANCER RESEARCH
- Multicenter Phase II Trial of YM155, a Small-Molecule Suppressor of Survivin, in Patients With Advanced, Refractory, Non–Small-Cell Lung Cancer
- (2009) Giuseppe Giaccone et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
- (2009) Pierre Fenaux et al. LANCET ONCOLOGY
- DNA hypomethylation in cancer cells
- (2009) Melanie Ehrlich Epigenomics
- Radiosensitizing Effect of YM155, a Novel Small-Molecule Survivin Suppressant, in Non-Small Cell Lung Cancer Cell Lines
- (2008) T. Iwasa et al. CLINICAL CANCER RESEARCH
- SPC3042: a proapoptotic survivin inhibitor
- (2008) J. B. Hansen et al. MOLECULAR CANCER THERAPEUTICS
- Interplay among BRCA1, SIRT1, and Survivin during BRCA1-Associated Tumorigenesis
- (2008) Rui-Hong Wang et al. MOLECULAR CELL
- Chemically synthesized human survivin does not inhibit caspase-3
- (2008) Changqing Li et al. PROTEIN SCIENCE
- Apoptin: Therapeutic Potential of an Early Sensor of Carcinogenic Transformation
- (2007) Claude Backendorf et al. Annual Review of Pharmacology and Toxicology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started